CASE STUDY: Staying Agile: How Leading Pharma Companies Use Integrated Business Planning as a Strategic Enabler to Build Resilience

CASE STUDY: Staying Agile: How Leading Pharma Companies Use Integrated Business Planning as a Strategic Enabler to Build Resilience

Day: LogiSYM Cold Chain 2024 - Day 2, 17 May
Start Time: 14:30
End Time: 15:00
Format: Case Study


SYNOPSIS

This keynote case study explores the strategies employed by leading pharmaceutical companies to maintain agility in the face of dynamic market conditions. Focusing on integrated business planning (IBP) as a strategic enabler, the presentation delves into how these companies leverage IBP to enhance resilience within their operations. Through real-world examples and insights, the session highlights the critical role of IBP in navigating uncertainties and achieving sustainable growth in the pharmaceutical industry.

SPEAKERS & PANELISTS

Speakers and panelists for this session are as follows:

Mark Woolf – Chief Strategy and Development Officer, Oximio
No Comments

Sorry, the comment form is closed at this time.

Malcare WordPress Security